4//SEC Filing
Forbion Growth Opportunities Fund I Cooperatief U.A. 4
Accession 0000950170-24-115607
CIK 0001980845other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:15 PM ET
Size
31.6 KB
Accession
0000950170-24-115607
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Shares
2024-09-27$5.94/sh+38,396$228,011→ 2,056,216 total - Purchase
Common Shares
2023-12-27$7.17/sh+2,750$19,711→ 2,002,750 total - Purchase
Common Shares
2024-09-27$6.38/sh+3,243$20,688→ 2,059,459 total - Purchase
Common Shares
2024-10-01$6.44/sh+35,279$227,158→ 2,436,070 total - Purchase
Common Shares
2024-10-07$6.55/sh+11,844$77,531→ 2,469,833 total - Purchase
Common Shares
2024-10-08$6.60/sh+800$5,278→ 2,470,633 total - Purchase
Common Shares
2023-12-29$8.30/sh+400$3,320→ 2,008,200 total - Purchase
Common Shares
2024-10-02$6.37/sh+10,153$64,697→ 2,446,223 total - Purchase
Common Shares
2024-10-04$6.54/sh+5,997$39,242→ 2,457,989 total - Purchase
Common Shares
2023-12-28$7.69/sh+5,050$38,827→ 2,007,800 total - Purchase
Common Shares
2023-12-29$9.09/sh+9,620$87,451→ 2,017,820 total - Purchase
Common Shares
2024-09-30$6.34/sh+341,332$2,163,362→ 2,400,791 total - Purchase
Common Shares
2024-10-03$6.48/sh+5,769$37,397→ 2,451,992 total
Holdings
- 3,765,932(indirect: By Forbion Growth Sponsor FEAC I B.V.)
Common Shares
Footnotes (14)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.10 to $7.37, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F10]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.435 to $6.585, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F11]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.50 to $6.62, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F12]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.42 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F13]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.59 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F14]Shares held by Forbion Growth Sponsor FEAC I B.V. ("Sponsor"). Sponsor is wholly owned by Forbion Cooperatief, and is controlled by a four-person Board of Managers comprised of J.M Bos, C. Lesser, S. Slootweg and W.S.J. Joustra ("Sponsor Board"). All voting and dispositive decisions with respect to the shares held by Sponsor are made by a majority vote of Sponsor Board. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.
- [F2]Shares held by Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Cooperatief"). Forbion Growth Management B.V. ("Forbion Management") is the sole director of Forbion Cooperatief and exercises voting and investment power through its investment committee (the "Management Investment Committee"), consisting of S. Slootweg, van Osch, G. J. Mulder, V. van Houten, D.A.F. Kersten, N.L. Luneborg, W.S.J. Joustra and J.M. Bos. None of the members of the Management Investment Committee has individual voting and investment power with respect to the securities reported herein. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.48 to $8.19, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.65 to $9.39, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.31 to $6.30, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F6]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.31 to $6.40, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F7]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F8]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.30 to $6.60, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F9]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.07 to $6.67, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
enGene Holdings Inc.
CIK 0001980845
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001911047
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:15 PM ET
- Size
- 31.6 KB